Cargando…

Dysregulation of tumor microenvironment promotes malignant progression and predicts risk of metastasis in bladder cancer

BACKGROUND: The tumor microenvironment (TME) is not only a key factor in the malignant progression of cancer but also plays an indispensable role in tumor immunotherapy. As an important regulatory factor in the TME, long non-coding RNAs (incRNA) are important for the development of bladder cancer. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ji, Zheng, Zongtai, Zhang, Wentao, Wan, Moxi, Ma, Wenchao, Wang, Ruiliang, Yan, Yang, Guo, Yadong, Zhang, Junfeng, Li, Wei, Yao, Xudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506754/ https://www.ncbi.nlm.nih.gov/pubmed/34733990 http://dx.doi.org/10.21037/atm-21-4023

Ejemplares similares

Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2020)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer
por: Guo, Yadong, et al.
Publicado: (2022)

Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway
por: Mao, Shiyu, et al.
Publicado: (2020)

Prognostic significance of red cell distribution width in bladder cancer
por: Ma, Wenchao, et al.
Publicado: (2020)

Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA
por: Mao, Shiyu, et al.
Publicado: (2021)

PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer
por: Shen, Liliang, et al.
Publicado: (2022)

Association between perioperative glucocorticoids and cancer metastasis and survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective study
por: Mao, Shiyu, et al.
Publicado: (2020)

N(6)-methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma
por: Zheng, Zongtai, et al.
Publicado: (2020)

A Genomic-Clinicopathologic Nomogram for the Prediction of Lymph Node Invasion in Prostate Cancer
por: Zheng, Zongtai, et al.
Publicado: (2021)

SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis
por: Huang, Jianhua, et al.
Publicado: (2021)

Causes of Death after Prostate Cancer Diagnosis: A Population-Based Study
por: Guo, Yadong, et al.
Publicado: (2022)

Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer
por: Zhang, Wentao, et al.
Publicado: (2018)

Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer
por: Zhang, Wentao, et al.
Publicado: (2022)

MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1
por: Zhang, Wentao, et al.
Publicado: (2019)

CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2022)

Recent Trends in the Incidence of Clear Cell Adenocarcinoma and Survival Outcomes: A SEER Analysis
por: Guo, Yadong, et al.
Publicado: (2022)

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1
por: Zhang, Wentao, et al.
Publicado: (2023)

O-GlcNAcylation Enhances NUSAP1 Stability and Promotes Bladder Cancer Aggressiveness
por: Chen, Yifan, et al.
Publicado: (2021)

Immunological perspective on the malignant progression of renal clear cell carcinoma
por: Liu, Ji, et al.
Publicado: (2021)

Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer
por: Guo, Yadong, et al.
Publicado: (2019)

CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT signaling pathway
por: Li, Cheng, et al.
Publicado: (2021)

Molecular subtypes, tumor microenvironment infiltration characterization and prognosis model based on cuproptosis in bladder cancer
por: Zhang, Heping, et al.
Publicado: (2023)

Effects of radical cystectomy, radiotherapy, and chemotherapy on the risk of long-term heart-specific death in bladder cancer patients
por: Yang, Fuhan, et al.
Publicado: (2021)

Prognostic Significance of Young Age and Non-Bone Metastasis at Diagnosis in Patients with Metastatic Prostate Cancer: a SEER Population-Based Data Analysis
por: Guo, Yadong, et al.
Publicado: (2019)

Bladder cancer-associated microbiota: Recent advances and future perspectives
por: Zhang, Wentao, et al.
Publicado: (2023)

Urological cancer organoids, patients' avatars for precision medicine: past, present and future
por: Chen, Haotian, et al.
Publicado: (2022)

Can Smoking Cause Differences in Urine Microbiome in Male Patients With Bladder Cancer? A Retrospective Study
por: Ma, Wenchao, et al.
Publicado: (2021)

MicroRNA-154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7
por: Zhang, Junfeng, et al.
Publicado: (2019)

Suppressed OGT expression inhibits cell proliferation and modulates EGFR expression in renal cell carcinoma
por: Wang, Longsheng, et al.
Publicado: (2019)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Down-Regulation of lncRNA MBNL1-AS1 Promotes Tumor Stem Cell-like Characteristics and Prostate Cancer Progression through miR-221-3p/CDKN1B/C-myc Axis
por: Liu, Ji, et al.
Publicado: (2022)

Downregulation of Long Noncoding RNA LUCAT1 Suppresses the Migration and Invasion of Bladder Cancer by Targeting miR-181c-5p
por: Chen, Yifan, et al.
Publicado: (2020)

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report
por: Mao, Shiyu, et al.
Publicado: (2019)

Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study
por: Guo, Yadong, et al.
Publicado: (2018)

Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer
por: Liu, Shenghua, et al.
Publicado: (2023)

Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer
por: Wang, Longsheng, et al.
Publicado: (2018)

Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy
por: Wang, Ruiliang, et al.
Publicado: (2019)

The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis
por: Wang, Li, et al.
Publicado: (2022)

Effects of Radiotherapy or Radical Prostatectomy on the Risk of Long-Term Heart-Specific Death in Patients With Prostate Cancer
por: Guo, Yadong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gl5r9ek1s2hsfgo05h18ripjuu